Private equity firms Avista Capital Partners and Nordic Capital have agreed to acquire biopharmaceutical business unit ConvaTec from Bristol-Myers Squibb Company for approximately $4.1bn, subject to adjustments based on ConvaTec's audited 2007 financial statements and closing working capital.
ConvaTec develops and markets wound therapeutics and ostomy care products. The company is headquartered in New Jersey, US and has more than 3,400 employees in 91 countries.
Nordic Capital will make the investment from its Nordic Capital VII fund.
Avista acquired Bristol-Myers Squibb Medical Imaging a few months ago for approximately $525m.
Russian Foreign Minister Sergei Lavrov stated that Vladimir Putin and Donald Trump, as well as the military of the two countries, will never let a military confrontation spark, but...
An attack is under way against the truth-seeking social media practising data democracy. What is unacceptable is that the liars accuse the truthseekers of lying
On April 20, Russian Foreign Minister Sergei Lavrov confirmed that Russia could supply air defense systems to Syria